Lee Ming-Yuan, Tsou Mei-Hua, Tan Tran-Der, Lu Mei-Chun
Department of Pathology and Laboratory Services, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan.
Eur J Haematol. 2005 Sep;75(3):221-6. doi: 10.1111/j.1600-0609.2005.00495.x.
The clinicopathological characteristics of malignant lymphomas vary according to geography, especially for the T-cell lymphoma (TCL). The aim of this study is to demonstrate the incidence and clinicopathological characteristics of TCL in Taiwan according to WHO classification.
Archival tissue from 600 malignant lymphomas during the period of 1995-2002 was retrieved, there were 74 cases diagnosed with TCL. Hematoxylin and eosin slides stained and other special studies were reviewed. All cases were reclassified according to the WHO classification. Clinical data, including age, gender, clinical staging, and follow-up, were scrutinized.
There were 52 males and 22 females with male predilectation. The incidence of TCL in malignant lymphoma was 12.3%. The most prevalent histologic subtype was peripheral T-cell lymphoma (PTCL), followed by nasal T-cell/Natural killer- (T-/NK-) cell lymphoma, T-lymphoblastic lymphoma (LBL), anaplastic large cell lymphoma, and enteropathy-type intestinal lymphoma (ETCL). Clinically, 39 cases (49%) had higher clinical stage (III/IV). Overall 2-year and 5-year survival rate was 51.4% and 34.7%, respectively. It was noteworthy that ETCL had high incidence rate (8.1%) and high mortality. There was significant difference in survival rates in respect of clinical stages and histological subtypes.
TCL is relatively less frequent in Taiwan, compared to other countries in Asian and western countries. The most common histological subtypes are PTCL, unspecified and T-/NK-cell lymphoma. Five-year survival rate is 34.7%. ETCL has higher incidence rate in Taiwan. The clinical stage and histological subtypes are prognostic parameters in determining the survival rates.
恶性淋巴瘤的临床病理特征因地域而异,尤其是T细胞淋巴瘤(TCL)。本研究旨在根据世界卫生组织(WHO)分类法阐述台湾地区TCL的发病率及临床病理特征。
检索1995年至2002年期间600例恶性淋巴瘤的存档组织,其中74例诊断为TCL。回顾苏木精和伊红染色切片及其他特殊检查。所有病例均根据WHO分类法重新分类。仔细审查临床资料,包括年龄、性别、临床分期及随访情况。
男性52例,女性22例,男性居多。TCL在恶性淋巴瘤中的发病率为12.3%。最常见的组织学亚型是外周T细胞淋巴瘤(PTCL),其次是鼻型T细胞/自然杀伤(T/NK)细胞淋巴瘤、T淋巴母细胞淋巴瘤(LBL)、间变性大细胞淋巴瘤和肠病型肠淋巴瘤(ETCL)。临床上,39例(49%)临床分期较高(III/IV期)。总体2年和5年生存率分别为51.4%和34.7%。值得注意的是,ETCL发病率高(8.1%)且死亡率高。临床分期和组织学亚型在生存率方面存在显著差异。
与亚洲其他国家和西方国家相比,TCL在台湾地区相对较少见。最常见的组织学亚型是PTCL,未特定型和T/NK细胞淋巴瘤。5年生存率为34.7%。ETCL在台湾地区发病率较高。临床分期和组织学亚型是决定生存率的预后参数。